% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

bergycb 103 posts  |  Last Activity: Sep 28, 2016 8:19 AM Member since: Sep 16, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I read those BDs and thought: this is sooo horrendous how in haites did they ever accept the nda to begin with?? Which of course runs 180 deg contrary to the letter written by the dozens of dmd docs and clinicians. Well think about it: accept the nda, stock shoots way up. Short the bejesus out if it. Release the BDs, cover. Annonce new adcom date and let speculation flie that the adcom got changed due to significant addendum to first BDs. Stock shoots up again upon said speculation. Short the bejesus out of it a second time, release the SAME EXACT BDs no with zero change to original opinion. Cover. The stock opens at 8 after adcom and now we sit here at 26. Its just hilarious. But whos pulling the triggers? Its bastings and Farkas, etc. Someone needs to examine them. If there was a dpo, i have a feeling it may not be because of job security. It was be to cover up stock manipulation. Think about it, if they back off of BD opinions now and say, yeah the drug should be approved, the first thing i would ask is: why the heck were you so over the top extreme with your briefing doc opinions/CONCLUSIONS?? And why are you flip flopping now??..........

  • Reply to

    This whole saga smacks of stock manipulation

    by bergycb Aug 15, 2016 1:34 PM
    bergycb bergycb Aug 15, 2016 1:47 PM Flag

    Farkas stuttering and stammering and sweating at adcom was such a tell

  • Reply to

    Gotta like the RBC report

    by thigrlsrk Sep 28, 2016 5:26 AM
    bergycb bergycb Sep 28, 2016 6:45 AM Flag

    And JMP from 60 to 90 price target raise. Cant wait to see Goldman and JPM price targets

    Sentiment: Hold

  • Reply to

    Cramer's a P#$*#y

    by latorra99 Sep 8, 2016 10:30 PM
    bergycb bergycb Sep 9, 2016 6:22 AM Flag

    Remember crammer tweeted : RIP $SRPT after adcom. The stock opened ~8 and rallied that day huge from there and soon after that crammer opined that he hoped etep would be approved. And now the stock is at 28.but he tweeted rip srpt. Great stuff, pretty much sums up the wall st types

  • Reply to

    Discreet Exit

    by speedbll Aug 23, 2016 5:14 PM
    bergycb bergycb Aug 23, 2016 7:15 PM Flag

    This is what worries me, if DNP has been up to Hamburg type securities manipulation, that might be part of the delay. I mean if, big if, Califf and Woodcock realized F and B were doing bushleague andor illegal type stuff during the etep review, it certainly would slow down the review. Then you throw in a dpo by F and B to try to cover their tracks, its just a total quagmire. I Hope we hear on a decision this week.

  • Reply to

    Heavy Pre-Market Activity

    by michaelwebbseattle Sep 28, 2016 8:08 AM
    bergycb bergycb Sep 28, 2016 8:19 AM Flag

    There have been filings for who bought into the recent offering, and how much of the over allotment. Check it out its impressive #s, these people can and will protect this investment

  • bergycb bergycb Sep 13, 2016 5:22 PM Flag

    Hope its true! Dont care if they got him for gross incompetence or securities fraud (ala hamburg) but that guy had to go, along with anyone else who blessed those BDs and the whole structure of the adcom

  • Reply to

    Drug Demand...

    by bionerd51 Sep 21, 2016 5:44 AM
    bergycb bergycb Sep 21, 2016 6:55 AM Flag

    And no need for a partnership, they obviously are in a very strong position.....

  • Reply to

    New theory

    by lender959 Sep 5, 2016 6:55 AM
    bergycb bergycb Sep 5, 2016 10:06 AM Flag

    Do you truly believe they have the guts to issue a crl with the current data set? You know as well as i there would be tremendous backlash from many fronts- parents, clinicians and many politicians. Hence if farkas and bastings have won out (and you have zero proof that they havent) they may be waiting for a more clear irrefutable smoking gun for political cover.....

  • It was one of the most bizarre scientific hearings i have ever witnessed. I mean just think the implications of Woodcock etc showing up to babysit Farkas (keeping in mind she didnt show up for drisa adcom). I see only two reasons why she would show up 1) she knew Farkas was off the deep end and had to let him know she was monitoring him closely. But that is an extreme measure and if it was the case why did JW let the BDs go out in first place?? Which leads to 2) she was simply there to be PC and diffuse much of the advocates anger when the vote went against etep. Then she slightly surprised me when she basically seemed to instruct the panel to vote for AA so i was leaning back toward 1). But at the end of adcom they voted against both FA and AA so i decided heck i have no idea maybe it was 2) , ie she was just there to cushion the advocate outrage

    But finally months later, if RF was pushed out, and it certainly appearst that way to me, it tells me it was scenario 1), ie JW was at the bizarre adcom to deal with a rogue reviewer- RF. I truly hope the Promovi data backs up AA and everything in this drawn out soap opera will (finally) make some sense....

  • Reply to

    New Word

    by speedbll Sep 5, 2016 10:22 AM
    bergycb bergycb Sep 5, 2016 10:31 AM Flag

    Imo SRPT has been Hamburg-ed. But in her case her husband was long jnj. So in this case srpt has been reverse Hamburglared!

  • Congrats longs

  • Reply to


    by marckot Sep 12, 2016 8:39 PM
    bergycb bergycb Sep 12, 2016 9:19 PM Flag

    And the comical early FRIDAY release of hatchet job BDs.......they had the cajones to claim the release was early because of public demand.......and 9 months later they still havnt given that same public an actual decision. The truth is stranger than fiction....

  • Reply to

    This whole saga smacks of stock manipulation

    by bergycb Aug 15, 2016 1:34 PM
    bergycb bergycb Aug 15, 2016 1:42 PM Flag

    And worth noting completely consistent to the #$%$ Hamburg is alleged to have pulled off

  • Reply to

    Do twitter search: fiercebiotech $srpt

    by bergycb Sep 21, 2016 6:47 AM
    bergycb bergycb Sep 21, 2016 6:51 AM Flag

    Contd.....and possibly most importantly he mentions NO need to seek a partnership for etep

  • Reply to

    New Word

    by speedbll Sep 5, 2016 10:22 AM
    bergycb bergycb Sep 5, 2016 9:52 PM Flag

    You notice the stuttering eye doctor didnt take on the dmd clinicians at adcom? The only smart thing he did at adcom. He would ve been fully exposed and he knows it

  • bergycb bergycb Sep 20, 2016 2:44 PM Flag

    Also google: ppmo approach. This is their nextgen strategy. Kaye and especially Krieg have indicated it is much more efficacious

  • Very informative interview w Ed Kaye, talks about NICE, the voucher, a potential raise, nextgen pipelinr, etc....

  • Reply to

    New theory

    by lender959 Sep 5, 2016 6:55 AM
    bergycb bergycb Sep 5, 2016 8:07 AM Flag

    Possible but sounds like youre reaching. Imo the further this goes on, its not dpo related, its either that full approval is on the table (which could be they are waiting for more data like 6mwt) OR the data from early this summer was not sufficient to make a decision, so they are waiting for more definitive later stage data (i.e. More D data, 6 mwt or serious AEs) to be able to say yea or nea. But either way to me, the longer this goes on it appears they are waiting to get more clinical data. Hope im wrong and this is resolved soon

  • Reply to

    The trend

    by marckot Sep 7, 2016 4:16 PM
    bergycb bergycb Sep 7, 2016 4:37 PM Flag

    Doesnt nec mean anything but it is worth noting that the current trend is 180 deg opposite than the trend right before the release of the disastrous BDs. Srpt was basically on a 45 deg angle down in the days leading up to early release of BDs. There definitely was a leak there, likely within fda. Now the stock is trending basically 45 deg angle up. Complete opposite trend, has there been another leak or are folk overly bullish?

3.42-0.03(-0.87%)Sep 29 4:00 PMEDT